国产大片一区二区三区黄色_免费亚洲婷婷国产99区_中文字幕,日韩有码,日韩无码_美女的裸体人人射人人操_中文写幕一区二区三区免费观成熟_中国精品三级片网站_这里有久久超级精品视频_日韩综合在线观看网站_无码av在线免费网站

• 位置 Location

  分別位于煙臺開發(fā)區(qū)八角街道白銀河以北區(qū)域、高新區(qū)核心區(qū)南部、牟平區(qū)沁水韓國工業(yè)園內(nèi)。

  The industry cluster is distributed in the north of the Baiyin River in Bajiao Subdistrict, Yantai Economic and Technological Development Area, the south of the core area of Yantai Hi-tech Industrial Development Zone, and in the Qinshui South Korea Industrial Park in Muping District.

• 集聚區(qū)名稱 Name

  ? ? ??海洋生物與醫(yī)養(yǎng)健康產(chǎn)業(yè)集聚區(qū)

  Marine biology and healthcare & elderly care industry cluster

  
  

• 招商方向 Direction of Investment Attraction

  培育壯大生物醫(yī)藥、醫(yī)療器械、海洋健康產(chǎn)品等優(yōu)勢產(chǎn)業(yè)，以及高技術(shù)醫(yī)藥研發(fā)和產(chǎn)業(yè)化服務(wù)外包。

  Focus will be on cultivating and expanding competitive industries such as biopharmaceuticals, medical devices and marine health products, as well as on high-tech pharmaceutical R&D and industrialization service outsourcing.

• 產(chǎn)業(yè)基礎(chǔ) Industrial Base

  集聚區(qū)內(nèi)擁有“國家火炬計劃海洋生物與醫(yī)藥特色產(chǎn)業(yè)基地”等多個國字號招牌，培育了一大批行業(yè)龍頭企業(yè)和細分領(lǐng)域骨干企業(yè)，擁有國家綜合性新藥研發(fā)技術(shù)大平臺示范企業(yè)3個、國家級省級企業(yè)技術(shù)中心20個，產(chǎn)品涵蓋生物制藥、醫(yī)療器械、診斷試劑與疫苗、現(xiàn)代中藥、生物保健品等多個領(lǐng)域。

  The industry cluster is currently home to a number of national brands, including the Special Industry Base of Marine Biology and Pharmaceuticals under the National Torch Plan. It also encompasses a significant number of industry-leading enterprises and backbone enterprises in various segments, as well as three demonstration enterprises under the National Comprehensive Platform for Drug Discovery and Development, and 20 enterprise technology centers at the national and provincial levels. Products in the industry cluster cover a wide range of areas, including biopharmaceuticals, medical devices, diagnostic reagents and vaccines, modern traditional Chinese medicine, and biological health products.

• 發(fā)展目標 Development Goal

  到2025年，落地世界500強及行業(yè)領(lǐng)軍企業(yè)項目14個，產(chǎn)業(yè)規(guī)模達到800億元。

  By 2025, 14 projects from Fortune Global 500 enterprises and industry-leading enterprises will have been implemented, with an industrial output up to RMB 80 billion.

• ?發(fā)展方向 Development Direction

  依托國家綜合性新藥研究開發(fā)技術(shù)大平臺煙臺基地等國家級創(chuàng)新平臺及一批龍頭企業(yè)，以海洋生物與醫(yī)藥科技研發(fā)為特色，以生物藥和高端醫(yī)療器械為核心，打造世界級生物醫(yī)藥產(chǎn)業(yè)集聚區(qū)、國際生物藥谷。

  Relying on the Yantai Base of the National Comprehensive Platform for Drug Discovery and Development and other national-level innovation platforms as well as a number of leading enterprises, efforts will be made to build a world-class biopharmaceutical industry cluster and an international biopharmaceutical base. Both the industry cluster and base will focus on the research and development of marine biological and pharmaceutical technologies, and will be centered on biopharmaceuticals and high-end medical devices.

說明：以上數(shù)據(jù)來源于第三方網(wǎng)絡(luò)，僅做投資參考！
Explanation: The above data is sourced from third-party networks and is for investment reference only!